The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts,formula (I) wherein A1, A2, A3 and L are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as aurora and KDR.
申请公布号
WO2011143430(A1)
申请公布日期
2011.11.17
申请号
WO2011US36250
申请日期
2011.05.12
申请人
ABBOTT LABORATORIES;MICHAELIDES, MICHAEL, R.;HOLMS, JAMES, H.;STEINMAN, DOUGLAS, H.
发明人
MICHAELIDES, MICHAEL, R.;HOLMS, JAMES, H.;STEINMAN, DOUGLAS, H.
